Teucrium launches 2x daily BNB ETF XBNB on NYSE Arca
Teucrium and xETFs launched XBNB on NYSE Arca on April 28, 2026, a swap-based 2x daily leveraged ETF providing regulated BNB exposure for short-term traders.
Teucrium and xETFs launched the Teucrium xETFs 2x Long Daily BNB ETF, which began trading under ticker XBNB on NYSE Arca on April 28, 2026. The actively managed fund seeks to deliver twice the daily performance of BNB before fees and expenses.
The ETF is swap-based and does not hold BNB directly. CFTC-registered swap dealer Falconx Bravo will provide liquidity and the derivative contracts that generate the fund’s exposure. Teucrium serves as investment adviser and xETFs is the sponsor.
XBNB targets a daily objective: two times the return of BNB for a single trading day. The fund rebalances each day, so returns over multi-day periods can diverge from twice BNB’s cumulative return. Compounding, volatility and the daily reset process can reduce returns and can cause losses even if BNB’s price is flat over time. Fund disclosures state there is no guarantee the ETF will meet its objective.
The product is marketed to traders seeking short-term, tactical exposure to BNB rather than long-term investors. Fund managers say the ETF offers regulated, exchange-traded access to amplified BNB price moves within a U.S.-listed vehicle.
Teucrium reported that its earlier leveraged crypto ETF, the Teucrium 2x Long Daily XRP ETF (XXRP), attracted hundreds of millions of dollars within months of launch and became the firm’s top product. In a statement, Springer Harris, Teucrium’s head of ETF solutions and chief operating officer, described the launch as “We are proud to partner with xETFs in the launch of their first fund.”
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.








